Unknown

Dataset Information

0

Chronic SSRI treatment exacerbates serotonin deficiency in humanized Tph2 mutant mice.


ABSTRACT: Selective serotonin reuptake inhibitors (SSRIs) are a major class of antidepressants that act by blocking inward transport of serotonin (5-HT) into presynaptic neurons mediated by the serotonin transporter (SERT). Both reuptake and ongoing synthesis are essential in supporting intraneuronal serotonin concentrations in serotonergic neurons. A rare mutation in tryptophan hydroxylase 2 (Tph2), the rate limiting enzyme for 5-HT synthesis, was identified in several patients with major depression, and knock-in mice expressing the analogous mutation (R439H Tph2 KI) show 80% reduction in 5-HT synthesis and tissue levels. Chronic treatment with SSRIs (fluoxetine and paroxetine) resulted in a dramatic further depletion of 5-HT tissue levels in R439H Tph2 KI mice (down to 1-3% of wild type levels) while having little effects in wild-type controls. Treatment with the 5-HT precursor 5-hydroxytryptophan (5-HTP) restored 5-HT tissue content in mutant mice, and cotreatment with 5-HTP and fluoxetine essentially prevented the depleting effect of a chronic SSRI. These data demonstrate that chronic SSRI treatment could further exacerbate the 5-HT deficiency in Tph2 mutation carriers, and this can be prevented by 5-HTP supplementation.

SUBMITTER: Siesser WB 

PROVIDER: S-EPMC3547473 | biostudies-literature | 2013 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Chronic SSRI treatment exacerbates serotonin deficiency in humanized Tph2 mutant mice.

Siesser William B WB   Sachs Benjamin D BD   Ramsey Amy J AJ   Sotnikova Tatyana D TD   Beaulieu Jean-Martin JM   Zhang Xiaodong X   Caron Marc G MG   Gainetdinov Raul R RR  

ACS chemical neuroscience 20121001 1


Selective serotonin reuptake inhibitors (SSRIs) are a major class of antidepressants that act by blocking inward transport of serotonin (5-HT) into presynaptic neurons mediated by the serotonin transporter (SERT). Both reuptake and ongoing synthesis are essential in supporting intraneuronal serotonin concentrations in serotonergic neurons. A rare mutation in tryptophan hydroxylase 2 (Tph2), the rate limiting enzyme for 5-HT synthesis, was identified in several patients with major depression, and  ...[more]

Similar Datasets

| S-EPMC4309973 | biostudies-literature
| S-EPMC3422228 | biostudies-other
| S-EPMC3536482 | biostudies-other
| S-EPMC4480945 | biostudies-literature
| S-EPMC2064626 | biostudies-literature
| S-EPMC8175951 | biostudies-literature
| S-EPMC5474748 | biostudies-literature
| S-EPMC3287108 | biostudies-literature
| S-EPMC8566580 | biostudies-literature
| S-EPMC5722931 | biostudies-literature